Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease

Detecting stable individual differences in the functional organization of the human basal ganglia

(2018) Manuel Garcia-Garcia et al.   NEUROIMAGE

Injury Markers but not Amyloid Markers are Associated with Rapid Progression from Mild Cognitive Impairment to Dementia in Alzheimer's Disease

(2018) Ineke A. van Rossum et al.   JOURNAL OF ALZHEIMERS DISEASE

Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807

(2018) David T. Chien et al.   JOURNAL OF ALZHEIMERS DISEASE

Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging

(2017) Anne Maass et al.   JOURNAL OF NEUROSCIENCE

Correlations of18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease

(2017) Ryuichi Harada et al.   JOURNAL OF NUCLEAR MEDICINE

Off-Target18F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation

(2017) Jae Yong Choi et al.   JOURNAL OF NUCLEAR MEDICINE

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

(2017) Giovanni B Frisoni et al.   LANCET NEUROLOGY

Tau pathology and cognitive reserve in Alzheimer's disease

(2017) Merle Christine Hoenig et al.   NEUROBIOLOGY OF AGING

Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease

(2017) Hanna Cho et al.   NEUROBIOLOGY OF AGING

AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure

(2017) Shruti Mishra et al.   NEUROIMAGE

Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease

(2017) Anne Maass et al.   NEUROIMAGE

In vivo staging of regional amyloid deposition

(2017) Michel J. Grothe et al.   NEUROLOGY

Elevated 18 F-AV-1451 PET tracer uptake detected in incidental imaging findings

(2017) Samuel N. Lockhart et al.   NEUROLOGY

Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain

(2017) Kok Pin Ng et al.   Alzheimers Research & Therapy

Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex

(2017) Jorge Sepulcre et al.   JAMA Neurology

Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease

(2017) Chenjie Xia et al.   JAMA Neurology

Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks

(2017) Oskar Hansson et al.   Frontiers in Neuroscience

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum

(2016) Hanna Cho et al.   ANNALS OF NEUROLOGY

[F-18]AV-1451 positron emission tomography retention in choroid plexus: More than “off-target” binding

(2016) Milos D. Ikonomovic et al.   ANNALS OF NEUROLOGY

Regional profiles of the candidate tau PET ligand18F-AV-1451 recapitulate key features of Braak histopathological stages

(2016) Adam J. Schwarz et al.   BRAIN

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease

(2016) Rik Ossenkoppele et al.   BRAIN

Increased basal ganglia binding of18F-AV-1451 in patients with progressive supranuclear palsy

(2016) Ruben Smith et al.   MOVEMENT DISORDERS

PET Imaging of Tau Deposition in the Aging Human Brain

(2016) Michael Schöll et al.   NEURON

Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration

(2016) Aleksandr Pankov et al.   NeuroImage-Clinical

An autoradiographic evaluation of AV-1451 Tau PET in dementia

(2016) Val J. Lowe et al.   Acta Neuropathologica Communications

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

(2015) Marta Marquié et al.   ANNALS OF NEUROLOGY

Tau positron emission tomographic imaging in aging and early Alzheimer disease

(2015) Keith A. Johnson et al.   ANNALS OF NEUROLOGY

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease

(2015) Kenichi Ota et al.   JOURNAL OF NEUROSCIENCE METHODS

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

(2015) Sebastian Palmqvist et al.   NEUROLOGY

The Richness of Task-Evoked Hemodynamic Responses Defines a Pseudohierarchy of Functionally Meaningful Brain Networks

(2014) Pierre Orban et al.   CEREBRAL CORTEX

[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

(2013) Chun-Fang Xia et al.   Alzheimers & Dementia

Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid

(2013) Susan M. Landau et al.   ANNALS OF NEUROLOGY

Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

(2012) Paul K. Crane et al.   Brain Imaging and Behavior

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

(2012) Peter T. Nelson et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Cognitive reserve in ageing and Alzheimer's disease

(2012) Yaakov Stern   LANCET NEUROLOGY

How golden is the gold standard of neuropathology in dementia?

(2011) Philip Scheltens et al.   Alzheimers & Dementia

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults

(2011) B. C. Dickerson et al.   NEUROLOGY

Multi-level bootstrap analysis of stable clusters in resting-state fMRI

(2010) Pierre Bellec et al.   NEUROIMAGE

Circular analysis in systems neuroscience: the dangers of double dipping

(2009) Nikolaus Kriegeskorte et al.   NATURE NEUROSCIENCE

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

(2009) Susan M. Landau et al.   NEUROBIOLOGY OF AGING

The measurement of everyday cognition (ECog): Scale development and psychometric properties.

(2008) Sarah Tomaszewski Farias et al.   NEUROPSYCHOLOGY